Cargando…
High Chromosome Number in hematological cancer cell lines is a Negative Predictor of Response to the inhibition of Aurora B and C by GSK1070916
BACKGROUND: Aurora kinases play critical roles in mitosis and are being evaluated as therapeutic targets in cancer. GSK1070916 is a potent, selective, ATP competitive inhibitor of Aurora kinase B and C. Translation of predictive biomarkers to the clinic can benefit patients by identifying the tumors...
Autores principales: | Moy, Christopher, Oleykowski, Catherine A, Plant, Ramona, Greshock, Joel, Jing, Junping, Bachman, Kurtis, Hardwicke, Mary Ann, Wooster, Richard, Degenhardt, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3146841/ https://www.ncbi.nlm.nih.gov/pubmed/21762492 http://dx.doi.org/10.1186/1479-5876-9-110 |
Ejemplares similares
-
Elevated ABCB1 Expression Confers Acquired Resistance to Aurora Kinase Inhibitor GSK-1070916 in Cancer Cells
por: Wu, Zhuo-Xun, et al.
Publicado: (2021) -
3D-QSAR and Molecular Docking Studies on Derivatives of MK-0457, GSK1070916 and SNS-314 as Inhibitors against Aurora B Kinase
por: Zhang, Baidong, et al.
Publicado: (2010) -
Combined Phosphatase and Tensin Homolog (PTEN) Loss and Fatty Acid Synthase (FAS) Overexpression Worsens the Prognosis of Chinese Patients with Hepatocellular Carcinoma
por: Zhu, Xuehua, et al.
Publicado: (2012) -
Loss and reduced expression of PTEN correlate with advanced-stage gastric carcinoma
por: ZHU, XUEHUA, et al.
Publicado: (2013) -
Aurora B puts chromosomes in their place
por: LeBrasseur, Nicole
Publicado: (2003)